Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Redx Pharma
Life Sciences
Phase I trial resumed
10 Jul 2019
Allergy Therapeutics plc
Life Sciences
Successful legal outcome removes uncertainty
01 Jul 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Oxford BioMedica
Life Sciences
Eying up long-term value
01 Jul 2019
Tissue Regenix
Life Sciences
Credit facilities expand cash runway to 2021
20 Jun 2019
Oxford BioMedica
Life Sciences
De-leveraging the balance sheet
18 Jun 2019
Allergy Therapeutics plc
Life Sciences
House dust mite vaccine – clinical progress
21 May 2019
Advanced Oncotherapy
Life Sciences
Commercialising a breakthrough technology
13 May 2019
Shield Therapeutics Plc
Life Sciences
All in the execution
13 May 2019
Advanced Oncotherapy
Life Sciences
Preparing for commercialisation
By
Dr Martin Hall
16 Apr 2019
ValiRx
Life Sciences
VAL401 is going forward
By
Dr Martin Hall
15 Apr 2019
Tissue Regenix
Life Sciences
Expanded GPO coverage secured
By
Dr Martin Hall
10 Apr 2019
Prev
1
...
8
9
10
11
12
...
22
Next
